학술논문
Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma.
Document Type
journal article
Author
O'Reilly, Eileen M.; Lee, Jonathan W.; Lowery, Maeve A.; Capanu, Marinela; Stadler, Zsofia K.; Moore, Malcolm J.; Dhani, Neesha; Kindler, Hedy L.; Estrella, Hayley; Maynard, Hannah; Golan, Talia; Segal, Amiel; Salo‐Mullen, Erin E.; Yu, Kenneth H.; Epstein, Andrew S.; Segal, Michal; Brenner, Robin; Do, Richard K.; Chen, Alice P.; Tang, Laura H.
Source
Cancer (0008543X); Apr2018, Vol. 124 Issue 7, p1374-1382, 9p
Subject
Language
ISSN
0008543X
Abstract
Copyright of Cancer (0008543X) is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)